Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changsheng Zheng

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Optics Letters|February 28, 2025
100 W orbital angular momentum laser at 2 µmHeng Ding, Zihao Tong, Changsheng Zheng, et al.
Applied Optics|March 4, 2024
Wavelength-tunable Tm:Y<sub>2</sub>O<sub>3</sub> ceramic vortex laser with a changeable orbital angular momentum stateTianyi Du, Changsheng Zheng, Xiangzhe Sun, et al.
Optics Express|December 19, 2025
Pushing mid-infrared Ho<sup>3+</sup>-doped laser ceramics power-scaling at 3 µm by synergistic phonon energy reduction and ionic deactivationQing Li, Weiwei Huang, Fei Liang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy-tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl)piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profileRobert O Hughes, D J Rogier, Rajesh Devraj, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 ActivityChu-Biao Xue, Lihua Chen, Ganfeng Cao, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potencyGeorge V De Lucca, Ui Tae Kim, Brian J Vargo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 AntagonistChu-Biao Xue, Hao Feng, Ganfeng Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Optics Letters|February 28, 2025
100 W orbital angular momentum laser at 2 µmHeng Ding, Zihao Tong, Changsheng Zheng, et al.
Applied Optics|March 4, 2024
Wavelength-tunable Tm:Y<sub>2</sub>O<sub>3</sub> ceramic vortex laser with a changeable orbital angular momentum stateTianyi Du, Changsheng Zheng, Xiangzhe Sun, et al.
Optics Express|December 19, 2025
Pushing mid-infrared Ho<sup>3+</sup>-doped laser ceramics power-scaling at 3 µm by synergistic phonon energy reduction and ionic deactivationQing Li, Weiwei Huang, Fei Liang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy-tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl)piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profileRobert O Hughes, D J Rogier, Rajesh Devraj, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 ActivityChu-Biao Xue, Lihua Chen, Ganfeng Cao, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potencyGeorge V De Lucca, Ui Tae Kim, Brian J Vargo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 AntagonistChu-Biao Xue, Hao Feng, Ganfeng Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Pageof 3